Abstract
Background/Objectives
To describe frequency and type of ocular manifestations in patients with cryoglobulinemic vasculitis (CV), as well as management approaches and outcomes.
Subjects/Methods
This was a retrospective, observational, cohort study of patients who were diagnosed with CV at a single center and regularly underwent a comprehensive ocular assessment.
Results
Ophthalmologic manifestations were recorded in 16 patients (28%). The diagnoses included dry eye disease and primary Sjögren syndrome in 5 and 2 patients, respectively; peripheral ulcerative keratitis and anterior scleritis in 1 patient each; hyperviscosity syndrome and hypertensive retinopathy in 2 patients each; and Purtscher- like retinopathy in 3 patients. Twelve patients (75%) were anti-HCV/HCV RNA-positive, 11 of whom achieved a sustained virologic response (SVR) following treatment with interferon-α2b plus ribavirin or direct-acting antivirals. All patients were treated with ocular lubricants. Systemic therapeutic measures, including glucocorticoids, immunosuppressive and biologic agents, induced the disappearance or ≥50% reduction of cryoglobulins and major signs of vasculitis in 11 patients (68.7%). In the remaining 5 patients (31.3%), cryoglobulins and CV manifestations remained unchanged or decreased by <50%. The corresponding ophthalmologic assessment showed a variable degree of improvement in the ocular symptoms in all but 2 patients (87.5%). The best corrected visual acuity following treatment improved in 26 eyes, was unchanged in 3 eyes, and worsened in 3 eyes.
Conclusions
Eye involvement is not a rare event in CV patients. A timely diagnosis and the correct employment of the available therapeutic measures may result in a favorable outcome of the ocular and extra-ocular manifestations.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 18 print issues and online access
$259.00 per year
only $14.39 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
Data are available upon request and are with the corresponding author. The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
Brouet JC, Clauvel JP, Danon F, Klein M, Seligmann M. Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am J Med. 1974;57:775–88.
Roccatello D, Saadoun D, Ramos-Casals M, Tzioufas AG, Fervenza FC, Cacoub P, et al. Cryoglobulinaemia. Nat Rev Dis Prim. 2018;4:11.
Dammacco F, Lauletta G, Russi S, Leone P, Tucci M, Manno C, et al. Clinical practice: hepatitis C virus infection, cryoglobulinemia and cryoglobulinemic vasculitis. Clin Exp Med. 2019;19:1–21.
Meltzer M, Franklin EC. Cryoglobulinemia–a study of twenty-nine patients. I. IgG and IgM cryoglobulins and factors affecting cryoprecipitability. Am J Med. 1966;40:828–36.
Meltzer M, Franklin EC, Elias K, McCluskey RT, Cooper N. Cryoglobulinemia–a clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity. Am J Med. 1966;40:837–56.
Ferri C, Greco F, Longombardo G, Palla P, Moretti A, Marzo E, et al. Antibodies against hepatitis C virus in mixed cryoglobulinemia patients. Infection 1991;19:417–20.
Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med. 1992;327:1490–5.
Dammacco F, Sansonno D. Antibodies to hepatitis C virus in essential mixed cryoglobulinaemia. Clin Exp Immunol 1992;87:352–6.
Trejo O, Ramos-Casals M, García-Carrasco M, Yagüe J, Jiménez S, de la Red G, et al. Cryoglobulinemia: study of etiologic factors and clinical and immunologic features in 443 patients from a single center. Medicine. 2001;80:252–62.
Terrier B, Marie I, Lacraz A, Belenotti P, Bonnet F, Chiche L, et al. Non HCV-related infectious cryoglobulinemia vasculitis: results from the French nationwide CryoVas survey and systematic review of the literature. J Autoimmun. 2015;65:74–81.
Galli M, Oreni L, Saccardo F, Castelnovo L, Filippini D, Marson P, et al. HCV-unrelated cryoglobulinaemic vasculitis: the results of a prospective observational study by the Italian Group for the Study of Cryoglobulinaemias (GISC). Clin Exp Rheumatol. 2017;35:67–76.
European Association for the Study of the Liver. EASL recommendations on treatment of hepatitis C: final update of the series. J Hepatol. 2020;73:1170–218.
Boleto G, Ghillani-Dalbin P, Musset L, Biard L, Mulier G, Cacoub P, et al. Cryoglobulinemia after the era of chronic hepatitis C infection. Semin Arthritis Rheum. 2020;50:695–700.
Dammacco F, Lauletta G, Vacca A. The wide spectrum of cryoglobulinemic vasculitis and an overview of therapeutic advancements. Clin Exp Med. 2023;23:255–72.
Ferri C, Sebastiani M, Giuggioli D, Cazzato M, Longombardo G, Antonelli A, et al. Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients. Semin Arthritis Rheum. 2004;33:355–74.
Ramos-Casals M, Stone JH, Cid MC, Bosch X. The cryoglobulinaemias. Lancet. 2012;379:348–60.
Sebastiani M, Giuggioli D, Colaci M, Fallahi P, Gragnani L, Antonelli A, et al. HCV441 related rheumatic manifestations and therapeutic strategies. Curr Drug Targets. 2017;18:803–10.
Mazzaro C, Quartuccio L, Adinolfi LE, Roccatello D, Pozzato G, Nevola R, et al. A review on extrahepatic manifestations of chronic hepatitis C virus infection and the impact of direct-acting antiviral therapy. Viruses. 2021;13:2249.
Mazzaro C, Dal Maso L, Mauro E, Gattei V, Ghersetti M, Bulian P, et al. Survival and prognostic factors in mixed cryoglobulinemia: data from 246 cases. Diseases. 2018;6:35.
Dammacco F, Sansonno D. Therapy for hepatitis C virus-related cryoglobulinemic vasculitis. N Engl J Med. 2013;369:1035–45.
Saadoun D, Landau DA, Calabrese LH, Cacoub PP. Hepatitis C-associated mixed cryoglobulinaemia: a crossroad between autoimmunity and lymphoproliferation. Rheumatology. 2007;46:1234–42.
Chiu CY, Cheng CK. Synergic effect of intravitreal bevacizumab and systemic corticosteroid in treating systemic inflammatory response syndrome (SIRS) associated purtscher-like retinopathy. Ocul Immunol Inflamm. 2023;31:421–5.
Ramos-Casals M, Solans R, Rosas J, Camps MT, Gil A, Del Pino-Montes J, et al. GEMESS Study Group. Primary Sjögren syndrome in Spain: clinical and immunologic expression in 1010 patients. Medicine. 2008;87:210–9.
Argyropoulou OD, Pezoulas V, Chatzis L, Critselis E, Gandolfo S, Ferro F, et al. Cryoglobulinemic vasculitis in primary Sjögren’s Syndrome: clinical presentation, association with lymphoma and comparison with Hepatitis C-related disease. Semin Arthritis Rheum. 2020;50:846–53.
Kedhar SR, Belair ML, Jun AS, Sulkowski M, Thorne JE. Scleritis and peripheral ulcerative keratitis with hepatitis C virus-related cryoglobulinemia. Arch Ophthalmol. 2007;125:852–3.
Johnson CC, Ohlstein DH. Peripheral ulcerative keratitis and necrotizing scleritis initiated by trauma in the setting of mixed cryoglobulinemia. Case Rep Ophthalmol. 2011;2:392–7.
Coelho P, Menezes C, Gonçalves R, Rodrigues P, Seara E. Peripheral ulcerative keratitis associated with HCV-related cryoglobulinemia. Case Rep Ophthalmol Med. 2017;2017:9461937.
Aiello F, Congliaro P, Malaspina C, Gallo Afflitto G, Nucci C. Peripheral ulcerative keratitis as the primary clinical manifestation of type 2 cryoglobulinemia. Can J Ophthalmol. 2021;56:e148–e150.
Wei DW, Pagnoux C, Chan CC. Peripheral ulcerative keratitis secondary to chronic hepatitis B infection. Cornea. 2017;36:515–7.
Doguizi S, Sekeroglu MA, Anayol MA, Yilmazbas P. A rare cause of unilateral central retinal vein occlusion in a young patient: type III mixed cryoglobulinemia. Case Rep Ophthalmol Med. 2016;2016:1949362.
Sebrow DB, Jung JJ, Horowitz J, Odel JG, Freund KB. Macular perivenous retinal whitening and presumed retino-ciliary sparing in a recurrent central retinal vein occlusion associated with the antiphospholipid syndrome and cryoglobulinemia. Retin Cases Brief Rep. 2018;12:159–165.
Takkar B, Azad SV, Kumar U, Venkatesh P. Extensive choroidal infarction in a case of mixed essential cryoglobulinaemia in a postpartum female. BMJ Case Rep. 2016;2016:bcr2016216513.
Salah S Jr, Imbeau L Jr, Le Lez ML, Regina S, Lioger B. Scleritis and retinal vasculitis associated with a type II mixed cryoglobulinemia. QJM. 2014;107:585–6.
Telander DG, Holland GN, Wax MB, Van Gelder RN. Rubeosis and anterior segment ischemia associated with systemic cryoglobulinemia. Am J Ophthalmol. 2006;142:689–90.
Cohen SM, Kokame GT, Gass JD. Paraproteinemias associated with serous detachments of the retinal pigment epithelium and neurosensory retina. Retina 1996;16:467–73.
Zamir E, Chowers I. Central serous chorioretinopathy in a patient with cryoglobulinaemia. Eye. 1999;13:265–6.
Myers JP, Di Bisceglie AM, Mann ES. Cryoglobulinemia associated with Purtscher like retinopathy. Am J Ophthalmol. 2001;131:802–4.
Sauer A, Nasica X, Zorn F, Petitjean P, Bader P, Speeg-Schatz C, et al. Cryoglobulinemia revealed by a Purtscher-like retinopathy. Clin Ophthalmol. 2007;1:555–7.
Chebil A, Mammouri R, Abdallah MB, El Matri L. Purtscher-like retinopathy as a rare presentation of cryoglobulinemia. Middle East Afr J Ophthalmol. 2016;23:219–21.
Cirasino L, Guatteri A, Sandri L, Baudo F, Silvani A, Morra E. Linfoma MALT delle ghiandole lacrimale e mammaria di sinistra, cirrosi epatica da HCV e crioglobulinemia di tipo II [MALT lymphoma of the left lacrimal and mammary glands, liver cirrhosis caused by HCV and type II cryoglobulinemia]. Recent Prog Med. 1998;89:79–81.
Donders PC. Clinical demonstrations: ophthalmological phenomena in Waldenström’s disease with cryoglobulinaemia. Ophthalmologica. 1958;135:324–6.
Ferri C, Mannini L, Bartoli V, Gremignai G, Genovesi-Ebert F, Cristofani R, et al. Blood viscosity and filtration abnormalities in mixed cryoglobulinemia patients. Clin Exp Rheumatol. 1990;8:271–81.
Cacoub P, Renou C, Rosenthal E, Cohen P, Loury I, Loustaud-Ratti V, et al. Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d’Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l’Hepatite C. Medicine. 2000;79:47–56.
Pawlotsky JM, Ben Yahia M, Andre C, Voisin MC, Intrator L, Roudot-Thoraval F, et al. Immunological disorders in C virus chronic active hepatitis: a prospective case control study. Hepatology. 1994;19:841–8.
Siagris D, Pharmakakis N, Christofidou M, Petropoulos JK, Vantzou C, Lekkou A, et al. Keratoconjunctivitis sicca and chronic HCV infection. Infection. 2002;30:229–33.
Verbaan H, Carlson J, Eriksson S, Larsson A, Liedholm R, Manthorpe R, et al. Extrahepatic manifestations of chronic hepatitis C infection and the interrelationship between primary Sjögren’s syndrome and hepatitis C in Swedish patients. J Intern Med. 1999;245:127–32.
Tripathy K, Patel BC. Purtscher retinopathy. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022.
Emery JS, Kuczynski M, La D, Almarzooqi S, Kowgier M, Shah H, et al. Efficacy and safety of direct acting antivirals for the treatment of mixed cryoglobulinemia. Am J Gastroenterol. 2017;112:1298–1308.
Gragnani L, Visentini M, Fognani E, Urraro T, De Santis A, Petraccia L, et al. Prospective study of guideline-tailored therapy with direct-acting antivirals for hepatitis C virus-associated mixed cryoglobulinemia. Hepatology. 2016;64:1473–82.
Sansonno D, Dammacco F. Hepatitis C virus, cryoglobulinaemia, and vasculitis: immune complex relations. Lancet Infect Dis. 2005;5:227–36.
Gross WL. New concepts in treatment protocols for severe systemic vasculitis. Curr Opin Rheumatol. 1999;11:41–6.
Galli M, Monti G, Marson P, Scaini P, Pietrogrande M, Candela M, et al. Recommendations for managing the manifestations of severe and life-threatening mixed cryoglobulinemia syndrome. Autoimmun Rev. 2019;18:778–85.
Dammacco F, Tucci FA, Lauletta G, Gatti P, De Re V, Conteduca V, et al. Pegylated interferon-alpha, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study. Blood 2010;116:343–53.
Ferri C, Cacoub P, Mazzaro C, Roccatello D, Scaini P, Sebastiani M, et al. Treatment with rituximab in patients with mixed cryoglobulinemia syndrome: results of multicenter cohort study and review of the literature. Autoimmun Rev. 2011;11:48–55.
Author information
Authors and Affiliations
Contributions
RD, GA and FD conceived and designed the study, retrieved, collected and had full access to all the data in the study, and take responsibility for the integrity of the data and the accuracy of the analysis. RD wrote the manuscript. LC and LDS revised the manuscript for important intellectual content and supplied additional images of Purtscher like retinopathy. All authors reviewed the manuscript, approved the draft submission, and accept responsibility for all aspects of this study.
Corresponding author
Ethics declarations
Competing interests
RD, LC, LDS, GA and FD certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or nonfinancial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials.
Ethical approval and consent to participate
All research and measurements adhered to the tenets of the Declaration of Helsinki.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Dammacco, R., Cimino, L., De Simone, L. et al. Ocular manifestations of cryoglobulinemia: a reappraisal. Eye 38, 585–593 (2024). https://doi.org/10.1038/s41433-023-02738-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41433-023-02738-y